Business Development
EG is aiming to find new licensors/suppliers for biotechnology, pharmaceutical & medical products for Egypt and Middle East North Africa (MENA) region. EG goal is to enhance its existence among Pharma business, through providing new products for Nephrology, Oncology & other segments from new licensors and expanding its sales in medical industry from new suppliers in EU, USA & China.
Benefits for Partners :
For our licensors/suppliers, an EG collaboration enhances their competitive profile, enable them to reach higher market share, allow them to maintain control of their products, and gain them access to EG's speed, capabilities and expertise.
Our focus :
EG is interested in considering late stage and already approved products. EG intends to grow both organically and by acquisition. Business Development team focuses on the 'search' aspect of the Development strategy, including acquisition of companies and in-licensing of commercialized products. We know that creating long-term productive relationships with our customers and the community we serve will encourage us to fulfill our mission.
To all prospective licensors/suppliers EG offers :
- Experienced management for prompt deal finalization.
- Strong capabilities within the Pharma & medical industry.
- Sales force of more than 200 people.
- Product development and regulatory capability.
- Results directed thinking.
EG is looking for Biotechnology, Pharmaceutical & Medical technology companies who wish to operate in Egypt and/or MENA region and those who already operates in Egypt and wants to experience remarkable growth opportunities.
For further information about EG partnering opportunities, please contact us at
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
.
|
